Alan J Flisher Centre for Public Mental Health, Department of Psychiatry and Mental Health, University of Cape Town, 46 Sawkins Road 7700 Rondebosch, Cape Town, South Africa.
Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.
BMC Psychiatry. 2018 Mar 6;18(1):61. doi: 10.1186/s12888-018-1642-x.
The Programme for Improving Mental Health Care (PRIME) sought to implement mental health care plans (MHCP) for four priority mental disorders (depression, alcohol use disorder, psychosis and epilepsy) into routine primary care in five low- and middle-income country districts. The impact of the MHCPs on disability was evaluated through establishment of priority disorder treatment cohorts. This paper describes the methodology of these PRIME cohorts.
One cohort for each disorder was recruited across some or all five districts: Sodo (Ethiopia), Sehore (India), Chitwan (Nepal), Dr. Kenneth Kaunda (South Africa) and Kamuli (Uganda), comprising 17 treatment cohorts in total (N = 2182). Participants were adults residing in the districts who were eligible to receive mental health treatment according to primary health care staff, trained by PRIME facilitators as per the district MHCP. Patients who screened positive for depression or AUD and who were not given a diagnosis by their clinicians (N = 709) were also recruited into comparison cohorts in Ethiopia, India, Nepal and South Africa. Caregivers of patients with epilepsy or psychosis were also recruited (N = 953), together with or on behalf of the person with a mental disorder, depending on the district. The target sample size was 200 (depression and AUD), or 150 (psychosis and epilepsy) patients initiating treatment in each recruiting district. Data collection activities were conducted by PRIME research teams. Participants completed follow-up assessments after 3 months (AUD and depression) or 6 months (psychosis and epilepsy), and after 12 months. Primary outcomes were impaired functioning, using the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS), and symptom severity, assessed using the Patient Health Questionnaire (depression), the Alcohol Use Disorder Identification Test (AUD), and number of seizures (epilepsy).
Cohort recruitment was a function of the clinical detection rate by primary health care staff, and did not meet all planned targets. The cross-country methodology reflected the pragmatic nature of the PRIME cohorts: while the heterogeneity in methods of recruitment was a consequence of differences in health systems and MHCPs, the use of the WHODAS as primary outcome measure will allow for comparison of functioning recovery across sites and disorders.
改善精神卫生保健计划(PRIME)旨在将针对四种重点精神障碍(抑郁症、酒精使用障碍、精神病和癫痫)的精神卫生保健计划(MHCP)纳入五个中低收入国家地区的常规初级保健中。通过建立重点疾病治疗队列,评估 MHCP 对残疾的影响。本文描述了这些 PRIME 队列的方法学。
在五个地区中的一些或全部地区招募了一个队列:埃塞俄比亚的 Sodo、印度的 Sehore、尼泊尔的 Chitwan、南非的 Dr. Kenneth Kaunda 和乌干达的 Kamuli,总共包括 17 个治疗队列(N=2182)。参与者是居住在这些地区的成年人,根据初级卫生保健工作人员的评估,有资格接受 MHCP 规定的精神卫生治疗,这些工作人员是由 PRIME 促进者根据地区 MHCP 进行培训的。在埃塞俄比亚、印度、尼泊尔和南非,还招募了筛查出患有抑郁症或 AUD 且未经临床医生诊断的患者(N=709)进入对照组。也招募了癫痫或精神病患者的照顾者(N=953),取决于地区,可以是代表患者,也可以是与患者一起。每个招募地区的目标样本量为 200 名(抑郁症和 AUD)或 150 名(精神病和癫痫)开始治疗的患者。PRIME 研究团队开展了数据收集活动。参与者在 3 个月(AUD 和抑郁症)或 6 个月(精神病和癫痫)后以及 12 个月后进行随访评估。主要结局指标是使用 12 项世界卫生组织残疾评估量表 2.0(WHODAS)评估的功能受损情况,以及使用患者健康问卷(抑郁症)、酒精使用障碍识别测试(AUD)和癫痫发作次数评估的症状严重程度。
队列招募是初级卫生保健工作人员临床检出率的一个功能,并没有达到所有计划目标。跨国方法反映了 PRIME 队列的务实性质:虽然招募方法的异质性是由于卫生系统和 MHCP 的差异造成的,但使用 WHODAS 作为主要结局测量将允许在不同地点和疾病之间比较功能恢复情况。